Reuters logo
Sun Pharmaceutical wins U.S. approval to buy Ranbaxy
2015年1月30日 / 晚上6点35分 / 3 年前

Sun Pharmaceutical wins U.S. approval to buy Ranbaxy

WASHINGTON, Jan 30 (Reuters) - Sun Pharmaceutical Industries Ltd has won U.S. approval to buy Ranbaxy Laboratories Ltd on condition that it sells its interest in a generic anti-bacterial medicine, the Federal Trade Commission said on Friday.

India’s Sun Pharmaceutical’s said in April that it had agreed to buy generic drugmaker Ranbaxy Laboratories Ltd for $3.2 billion from the current owner, Japan’s Daiichi Sankyo Co . (Reporting by Diane Bartz)

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below